Advertisement

Vitiligo pp 381-398 | Cite as

Surgical Therapies

  • Boon Kee Goh
Chapter

Abstract

Cellular grafting for vitiligo has evolved since its inception. Non-cultured cellular grafting has superseded cultured techniques as the preferred modus operandi in clinical practice. The reasons are straightforward: it can be completed in a few hours, does not require the use of xenobiotics (except trypsin) or culture media and is of significantly lower costs. Although it does not offer the possibility of cell expansion and cryopreservation for future transplant, this can be supplanted by harvesting a new piece ultrathin split skin graft. Under proper training, harvesting an ultrathin split skin graft (not beyond the papillary dermis) is fast and results in no or minimal scarring. Innovative methods to simplify non-cultured cellular grafting have also been successfully achieved.

Melanocytes can now be extracted not only from the epidermis for transplantation but from outer root sheath of hair follicles.

Non-cultured cellular grafting has proven to be a safe and effective surgical treatment for stable vitiligo, substantiated by various long-term studies over the last two decades. The imposition of strict legislative regulation on this technique is unwarranted and will only drive up cost and deprive patients’ access to this innovative procedure.

References

  1. 1.
    Hartmann A, Broecker EB, Hamm H. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension. J Eur Acad Dermatol Venereol. 2008;22:624–6.CrossRefGoogle Scholar
  2. 2.
    Gan EY, van Geel N, Goh BK. Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting. Br J Dermatol. 2012;166:196–9.CrossRefGoogle Scholar
  3. 3.
    Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A. 1982;79:2018–22.CrossRefGoogle Scholar
  4. 4.
    Halaban R, Ghosh S, Duray P, Kirkwood JM, Lerner AB. Human melanocytes cultured from naevi and melanomas. J Invest Dermatol. 1986;87:95–101.CrossRefGoogle Scholar
  5. 5.
    Lerner A, Halaban R, Klaus SN, Moellman GE. Transplantation of human melanocytes. J Invest Dermatol. 1987;89:219–24.CrossRefGoogle Scholar
  6. 6.
    Halaban R, Langdon R, Birchall N, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol. 1988;107:1611–9.CrossRefGoogle Scholar
  7. 7.
    Olsson MJ, Juhlin L. Repigmentation of vitiligo by transplantation of cultured autologous melanocytes. Acta Derm Venereol. 1993;73:49–51.PubMedGoogle Scholar
  8. 8.
    Löntz W, Olsson MJ, Moellmann G, Lerner AB. Pigment cell transplantation for the treatment of vitiligo: a progress report. J Am Acad Dermatol. 1994;30:591–7.CrossRefGoogle Scholar
  9. 9.
    Olsson MJ, Moellman G, Lerner AB, Juhlin L. Vitiligo: repigmentation with cultured melanocytes after cryostorage. Acta Derm Venereol. 1994;74:226–8.PubMedGoogle Scholar
  10. 10.
    Kaufmann R, Greiner D, Kippenberger S, Bernd A. Grafting of in vitro cultured melanocytes onto laser-ablated lesions of vitiligo. Acta Derm Venereol. 1998;78:136–8.CrossRefGoogle Scholar
  11. 11.
    Dover JS, Hruza G. Lasers in skin resurfacing. Australas J Dermatol. 2000;41:72–85.CrossRefGoogle Scholar
  12. 12.
    Olsson MJ, Juhlin L. Transplantation of melanocytes in vitiligo. Br J Dermatol. 1995;132:587–91.CrossRefGoogle Scholar
  13. 13.
    Chen YF, Yang PY, Hu DH, Kuo FS, Hung CS, Hung CM. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol. 2004;51:68–74.CrossRefGoogle Scholar
  14. 14.
    O’Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet. 1981;1:75–8.CrossRefGoogle Scholar
  15. 15.
    Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O’Connor NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. Lab Investig. 1989;60:600–12.PubMedGoogle Scholar
  16. 16.
    Brysk MM, Newton RC, Rajaraman S, et al. Repigmentation of vitiliginous skin by cultured cells. Pigment Cell Res. 1989;2:202–7.CrossRefGoogle Scholar
  17. 17.
    Plott RT, Brysk MM, Newton RC, Raimer SS, Rajaraman S. A surgical treatment for vitiligo: autologous cultured-epithelial grafts. J Dermatol Surg Oncol. 1989;15:1161–6.CrossRefGoogle Scholar
  18. 18.
    Falabella R, Escobar C, Borrero I. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol. 1989;21:257–64.CrossRefGoogle Scholar
  19. 19.
    Falabella R, Escobar C, Borrero I. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol. 1992;26:230–6.CrossRefGoogle Scholar
  20. 20.
    Andreassi L, Pianigiani E, Andreassi A, Taddeucci P, Biagioli M. A new model of epidermal culture for the surgical treatment of vitiligo. Int J Dermatol. 1998;37:595–8.CrossRefGoogle Scholar
  21. 21.
    Eves PC, Beck AJ, Shard AG, MacNeil S. A chemically defined surface for the co-culture of melanocytes and keratinocytes. Biomaterials. 2005;26:7068–81.CrossRefGoogle Scholar
  22. 22.
    Beck AJ, Phillips J, Smith-Thomas L, Short RD, Mac Neil S. Development of a plasma-polymerised surface suitable for the transplantation of keratinocyte-melanocyte cocultures for patients with vitiligo. Tissue Eng. 2004;9:1123–1131.Google Scholar
  23. 23.
    MacNeil S, Eves P, Beck A, Gawkrodger D. Practical issues of delivering cultured melanocytes to vitiligo patients. Proceedings of the 19th International Pigment Cell Conference, VA, USA; 2005.Google Scholar
  24. 24.
    Gauthier Y, Surleve-Bazeille J. Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol. 1992;26:191–4.CrossRefGoogle Scholar
  25. 25.
    Olsson MJ, Juhlin L. Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br J Dermatol. 1998;138:644–8.CrossRefGoogle Scholar
  26. 26.
    Van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg. 2001;27:873–6.PubMedGoogle Scholar
  27. 27.
    Van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, Naeyaert JM. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol. 2004;140:1–6.Google Scholar
  28. 28.
    Gan EY, Kong YL, Tan WD, Thng ST, Goh BK. Twelve-month and sixty-month outcomes of noncultured cellular grafting for vitiligo. J Am Acad Dermatol. 2016;75:564–71.CrossRefGoogle Scholar
  29. 29.
    Olsson MJ, Juhlin L. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol. 2002;147:893–904.CrossRefGoogle Scholar
  30. 30.
    Mulekar SV. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte- keratinocyte cell transplantation. Arch Dermatol. 2004;140:1211–5.CrossRefGoogle Scholar
  31. 31.
    Van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol. 2010;163:1186–93.CrossRefGoogle Scholar
  32. 32.
    Rao A, Gupta S, Dinda AK, et al. Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation. Br J Dermatol. 2012;166:1230–6.CrossRefGoogle Scholar
  33. 33.
    Tegta GR, Parsad D, Majumdar S, Kumar B. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo. Int J Dermatol. 2006;45:106–10.CrossRefGoogle Scholar
  34. 34.
    Inger R, Hans R. An estimation of the melanocyte mass in humans. J Invest Dermatol. 1983;81:278–81.CrossRefGoogle Scholar
  35. 35.
    Mulekar SV, Ghwish B, Al Issa A, Al Eisa A. Treatment of vitiligo lesions by ReCell® vs. conventional melanocyte–keratinocyte transplantation: a pilot study. Br J Dermatol. 2008;158:45–9.PubMedGoogle Scholar
  36. 36.
    Goh BK, Chua XM, Chong KL, De Mil M, Van Geel NAC. Simplified cellular grafting for treatment of vitiligo and piebaldism: the “6-well plate” technique. Dermatol Surg. 2010;36:203–7.CrossRefGoogle Scholar
  37. 37.
    Kumar R, Parsad D, Singh C, Yadav S. Four compartment method: a simplified and cost-effective method of noncultured epidermal cell suspension for the treatment of vitiligo. Br J Dermatol. 2014;170:581–5.CrossRefGoogle Scholar
  38. 38.
    Gupta S, Sahni K, Tembhre MJ, Mathur S, Sharma VK. A novel point-of-care in vivo technique for preparation of epidermal cell suspension for transplantation in vitiligo. J Am Acad Dermatol. 2015;72:e65–6.CrossRefGoogle Scholar
  39. 39.
    Randall VA, Jenner TJ, Hibberts NA, et al. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles. J Endocrinol. 2008;197:11–23.CrossRefGoogle Scholar
  40. 40.
    Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29–54.CrossRefGoogle Scholar
  41. 41.
    Legue E, Sequeira I, Nicolas JF. Hair follicle renewal: authentic morphogenesis that depends on a complex progression of stem cell lineages. Development. 2010;137:569–77.CrossRefGoogle Scholar
  42. 42.
    Vanscheidt W, Hunziker T. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology. 2009;218:342–3.CrossRefGoogle Scholar
  43. 43.
    Kumar A, Gupta S, Mohanty S, Bhargava B, Airan B. Stem cell niche is partially lost during follicular plucking: a preliminary pilot study. Int J Trichol. 2013;5(2):97–100.CrossRefGoogle Scholar
  44. 44.
    Mohanty S, Kumar A, Dhawan J, Sreenivas V, Gupta S. Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo. Br J Dermatol. 2011;164:1241–6.CrossRefGoogle Scholar
  45. 45.
    Vinay K, Dogra S, Parsad D, Kanwar AJ, Kumar R, Minz RW, Saikia UN. Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo. J Eur Acad Dermatol Venereol. 2015;29:31–7.CrossRefGoogle Scholar
  46. 46.
    Singh C, Parsad D, Kanwar AJ, Dogra S, Kumar R. Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous non cultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol. 2013;169:287–93.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Boon Kee Goh
    • 1
  1. 1.Skin Physicians Pte LtdMount Elizabeth Medical CentreSingaporeSingapore

Personalised recommendations